1. Home
  2. CLIR vs GBIO Comparison

CLIR vs GBIO Comparison

Compare CLIR & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearSign Technologies Corporation (DE)

CLIR

ClearSign Technologies Corporation (DE)

HOLD

Current Price

$0.58

Market Cap

33.4M

Sector

Industrials

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.34

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLIR
GBIO
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.4M
36.3M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
CLIR
GBIO
Price
$0.58
$5.34
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$2.00
$8.88
AVG Volume (30 Days)
115.2K
133.1K
Earning Date
11-14-2025
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,153,000.00
$15,270,000.00
Revenue This Year
$13.13
N/A
Revenue Next Year
$143.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$3.00
52 Week High
$1.12
$8.40

Technical Indicators

Market Signals
Indicator
CLIR
GBIO
Relative Strength Index (RSI) 42.72 39.79
Support Level $0.55 $5.47
Resistance Level $0.70 $5.77
Average True Range (ATR) 0.06 0.17
MACD -0.00 -0.02
Stochastic Oscillator 22.58 0.00

Price Performance

Historical Comparison
CLIR
GBIO

About CLIR ClearSign Technologies Corporation (DE)

ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: